日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptomic comparison of human intestinal organoids and Caco-2 cells in modeling nutrient absorption: insights from infant formula and breast milk

人类肠道类器官与Caco-2细胞在模拟营养吸收方面的转录组学比较:来自婴儿配方奶粉和母乳的启示

Wang, Xianli; Zhang, Wenchuan; Yang, Shangzhi; Zheng, Chengdong; Wang, Zening; Yang, Guitao; Huang, Chenxuan; Yao, Haiyang; Huang, Kainan; Yan, Yuanyuan; Jiang, Shilong; Sun, Jianguo; Xie, Qinggang; Zhang, Yongjiu; Li, Xiaoguang; Wang, Hui

Editorial: Exploring molecular mechanisms and novel diagnostics in cardiovascular disease treatment

社论:探索心血管疾病治疗中的分子机制和新型诊断方法

Sun, Jianguo; Liu, Yiwei; Peng, Qianman

Laparoscopic management of a rare intrahepatic bile duct variation in a patient with cholelithiasis: a case report and review of the literature

腹腔镜治疗胆结石患者罕见的肝内胆管变异:病例报告及文献复习

Zhang, Ruixiang; Xu, Fugui; Li, Yunlong; Sun, Jianguo; Wei, Jianwen; Ding, Tianlong

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

肿瘤治疗相关皮肤副作用的管理:亚洲视角下的皮肤化妆品应用

Pan, Meng; Sun, Jianguo; Kawashima, Makoto; Kim, You Chan; Chun, Mison; Chu, Chia-Yu; Liang, Yi-Hsin; Chang, Mee; Kerob, Delphine; Dreno, Brigitte

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial

在中国RAS/BRAF野生型转移性结直肠癌患者中,一线治疗方案为抗EGFR单克隆抗体西妥昔单抗β联合FOLFIRI方案与单用FOLFIRI方案的比较:一项随机、3期临床试验

Shi, Yuankai; Ba, Yi; Wang, Junye; Xiong, Jianping; Gu, Kangsheng; Chen, Yigui; Zheng, Zhendong; Wang, Zishu; Guo, Weijian; Cheng, Ying; Yin, Xianli; Liu, Yunpeng; Bai, Yuxian; Li, Enxiao; Li, Qi; Zhu, Liangjun; Li, Wei; Jiang, Da; He, Jingdong; Chen, Jiansi; Sun, Jianguo; Hou, Sheng

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

PACIFIC-5:一项针对不可切除的 III 期非小细胞肺癌患者,在同步或序贯放化疗后未出现疾病进展的情况下,进行度伐利尤单抗巩固治疗的 III 期临床试验

Wu, Yi-Long; Wu, Lin; Bi, Nan; Cil, Timucin; Ge, Hong; Zhu, Zhengfei; Wang, Chih-Liang; Zhang, Wei; Lv, Dongqing; Mingyan, E; Sun, Jianguo; Pan, Yi; Krzakowski, Maciej; Dikilitas, Mustafa; Sendur, Mehmet Ali Nahit; Kim, Young-Chul; Yang, Yanjiao; Mao, Rui; Zhang, Biao; Wang, Luhua

Wide-Temperature Electrolytes for Aqueous Alkali Metal-Ion Batteries: Challenges, Progress, and Prospects

水系碱金属离子电池宽温电解液:挑战、进展与展望

Lin, Zichen; Cai, Yongzhou; Zhang, Shilin; Sun, Jianguo; Liu, Yu; Zheng, Yang; Huo, Kaifu

Engineering a functionality-integrated artificial cornea stromal Substitute: Janus bio-adhesive implant with a collagen-based multi-scale biomimetic skeleton

构建功能一体化的人工角膜基质替代物:具有胶原蛋白基多尺度仿生骨架的 Janus 生物粘附植入物

Lei, Miao; Ji, Yue; Zhang, Shaohua; Hou, Bing; Lu, Yi; Sun, Jianguo; Liu, Changsheng; Qu, Xue

Water-Enhanced Multicolor Electrochromism in Nickel-Catecholate MOFs

水增强镍儿茶酚金属有机框架材料的多色电致变色

Zhao, Qi; Yang, Jing; Wang, Xingyang; Wang, Wanwan; Gao, Yulin; Chen, Xue; Sun, Jianguo; Yuan, Hao; Liu, Yu; Park, Jinwoo; Ting, Lewis Kien Juen; Wang, Qing; Lee, Pooi See; Gao, Yanfeng; Zhang, Yong-Wei; Wang, John

Corrigendum to "Disturbance of bile acids profile aggravates the diarrhea induced by capecitabine through inhibiting the Wnt/β-catenin pathway" [J. Adv. Res. 72 (2025) 591-604]

对“胆汁酸谱紊乱通过抑制 Wnt/β-catenin 通路加重卡培他滨引起的腹泻”的更正 [J. Adv. Res. 72 (2025) 591-604]

Wang, Zhipeng; Liu, Zhijun; Cui, Lili; Sun, Jianguo; Bu, Chen; Tang, Mao; Li, Mingming; Gao, Shouhong; Chen, Wansheng; Tao, Xia